000			02321 a2200673 4500
005			20250515005049.0
264		0	_c20060126
008			200601s 0 0 eng d
022			_a0167-594X
024	7		_a10.1007/s11060-005-3671-9 _2doi
040			_aNLM _beng _cNLM
100	1		_aKararizou, E
245	0	0	_aParaneoplastic limbic encephalitis presenting as acute viral encephalitis. _h[electronic resource]
260			_bJournal of neuro-oncology _cNov 2005
300			_a229-32 p. _bdigital
500			_aPublication Type: Case Reports; Comparative Study; Letter
650	0	4	_aAcute Disease
650	0	4	_aAcyclovir _xtherapeutic use
650	0	4	_aAnti-Bacterial Agents _xtherapeutic use
650	0	4	_aAnticonvulsants _xtherapeutic use
650	0	4	_aCarcinoma, Renal Cell _xcomplications
650	0	4	_aCerebrospinal Fluid _xmicrobiology
650	0	4	_aDiagnosis, Differential
650	0	4	_aDrug Therapy, Combination
650	0	4	_aElectroencephalography
650	0	4	_aEncephalitis, Viral _xcerebrospinal fluid
650	0	4	_aEnoxaparin _xtherapeutic use
650	0	4	_aEthambutol _xtherapeutic use
650	0	4	_aFollow-Up Studies
650	0	4	_aHerpesvirus 1, Human _xdrug effects
650	0	4	_aHumans
650	0	4	_aIsoniazid _xtherapeutic use
650	0	4	_aLimbic Encephalitis _xdrug therapy
650	0	4	_aLimbic System _xpathology
650	0	4	_aMagnetic Resonance Imaging
650	0	4	_aMale
650	0	4	_aMeningoencephalitis _xdiagnosis
650	0	4	_aMethylprednisolone _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aNephrectomy
650	0	4	_aNeuropsychological Tests
650	0	4	_aParaneoplastic Syndromes, Nervous System _xdiagnosis
650	0	4	_aPhenytoin _xtherapeutic use
650	0	4	_aRifampin _xtherapeutic use
650	0	4	_aTime Factors
650	0	4	_aTomography, X-Ray Computed
650	0	4	_aTreatment Outcome
650	0	4	_aVancomycin _xtherapeutic use
700	1		_aMarkou, I
700	1		_aZalonis, I
700	1		_aGkiatas, K
700	1		_aTriantafyllou, N
700	1		_aKararizos, G
700	1		_aLikomanos, D
700	1		_aZambelis, T
700	1		_aVassilopoulos, D
773	0		_tJournal of neuro-oncology _gvol. 75 _gno. 2 _gp. 229-32
856	4	0	_uhttps://doi.org/10.1007/s11060-005-3671-9 _zAvailable from publisher's website
999			_c15907976 _d15907976